Skip to Content

Cancers, Volume 12, Issue 8

2020 August - 335 articles

Cover Story: Accumulating evidence underlines that both somatic mutations and epigenetic alterations are involved in the pathogenesis of malignant melanoma, especially upregulated expression of oncogenic microRNA-21. Recent research focuses on exosomes enriched in microRNA-21 that promote melanomagenesis and melanoma progression. This review presents various sources of microRNA-21-enriched exosomes including UV-irradiated keratinocytes, adipocyte-derived exosomes in obesity, airway epithelium-derived exosomes generated by smoking and pollution, diet-related exosomes such as cow milk exosomes and inflammation-induced exosomes, which may synergistically increase the exosomal microRNA-21 burden of melanocyte, the transformed melanoma cell and its tumor environment. Exposure to modern lifestyle factors thus increases exosomal microRNA-21 signaling promoting melanoma and most likely other common cancers of Western societies. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (335)

  • Article
  • Open Access
21 Citations
5,197 Views
15 Pages

Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment

  • Katharina Kriegsmann,
  • Michael Hundemer,
  • Nicole Hofmeister-Mielke,
  • Philipp Reichert,
  • Calin-Petru Manta,
  • Mohamed H.S. Awwad,
  • Sandra Sauer,
  • Uta Bertsch,
  • Britta Besemer and
  • for the German-speaking Myeloma Multicenter Group (GMMG)
  • + 10 authors

18 August 2020

In order to meet the challenges in data evaluation and comparability between studies in multiple myeloma (MM) minimal residual disease (MRD) assessment, the goal of the current study was to provide a step-by-step evaluation of next-generation sequenc...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
13 Citations
4,972 Views
16 Pages

Extracellular Vesicle-Based Communication May Contribute to the Co-Evolution of Cancer Stem Cells and Cancer-Associated Fibroblasts in Anti-Cancer Therapy

  • Gábor Valcz,
  • Edit I. Buzás,
  • Anna Sebestyén,
  • Tibor Krenács,
  • Zoltán Szállási,
  • Péter Igaz and
  • Béla Molnár

18 August 2020

Analogously to the natural selective forces in ecosystems, therapies impose selective pressure on cancer cells within tumors. Some tumor cells can adapt to this stress and are able to form resistant subpopulations, parallel with enrichment of cancer...

(This article belongs to the Special Issue Tumor Evolution: Progression, Metastasis and Therapeutic Response)
  • Article
  • Open Access
31 Citations
3,880 Views
13 Pages

Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer

  • Hyunju Park,
  • Jun Park,
  • So Young Park,
  • Tae Hyuk Kim,
  • Sun Wook Kim and
  • Jae Hoon Chung

18 August 2020

Because of the low mortality rate of well-differentiated thyroid cancer (WDTC), investigation of the clinical course leading to death is limited. We analyzed the cause of death and clinical course from diagnosis to death in patients who died of WDTC....

  • Perspective
  • Open Access
66 Citations
9,409 Views
13 Pages

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer

  • Carlo Cattrini,
  • Melissa Bersanelli,
  • Maria Maddalena Latocca,
  • Benedetta Conte,
  • Giacomo Vallome and
  • Francesco Boccardo

18 August 2020

The novel coronavirus disease 2019 (COVID-19) shows a wide spectrum of clinical presentations, severity, and fatality rates. The reason older patients and males show increased risk of severe disease and death remains uncertain. Sex hormones, such as...

(This article belongs to the Collection The Impact of COVID-19 Infection in Cancer)
  • Feature Paper
  • Review
  • Open Access
22 Citations
7,068 Views
36 Pages

18 August 2020

Src family kinases (SFKs) constitute the biggest family of non-receptor tyrosine kinases considered as therapeutic targets for cancer therapy. An aberrant expression and/or activation of the proto-oncogene c-Src kinase, which is the oldest and most s...

(This article belongs to the Special Issue The Role of Src Kinase Family in Cancer)
  • Review
  • Open Access
11 Citations
6,249 Views
24 Pages

Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction

  • Artemis Gavriil,
  • Marta Barisa,
  • Emma Halliwell and
  • John Anderson

18 August 2020

The clinical successes of chimeric antigen receptor (CAR)-T-cell therapy targeting cell surface antigens in B cell leukaemias and lymphomas has demonstrated the proof of concept that appropriately engineered T-cells have the capacity to destroy advan...

(This article belongs to the Special Issue CAR-T Cell in Human Cancers: Combinations, Gene-Editing, Payload Delivery, Autonomous Control and Synthetic Biology)
  • Article
  • Open Access
20 Citations
4,512 Views
18 Pages

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

  • Corinna Kosnopfel,
  • Tobias Sinnberg,
  • Birgit Sauer,
  • Heike Niessner,
  • Alina Muenchow,
  • Birgit Fehrenbacher,
  • Martin Schaller,
  • Peter R. Mertens,
  • Claus Garbe and
  • Birgit Schittek
  • + 1 author

18 August 2020

Secreted factors play an important role in intercellular communication. Therefore, they are not only indispensable for the regulation of various physiological processes but can also decisively advance the development and progression of tumours. In th...

(This article belongs to the Special Issue Close links between Cold Shock Proteins and Cancer)
  • Article
  • Open Access
40 Citations
5,816 Views
20 Pages

Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma

  • Luca Engelmann,
  • Julia Thierauf,
  • Natalia Koerich Laureano,
  • Hans-Juergen Stark,
  • Elena-Sophie Prigge,
  • Dominik Horn,
  • Kolja Freier,
  • Niels Grabe,
  • Chao Rong and
  • Annette Affolter
  • + 6 authors

18 August 2020

Background: Head and neck squamous cell carcinomas (HNSCC) are phenotypically and molecularly heterogeneous and frequently develop therapy resistance. Reliable patient-derived 3D tumor models are urgently needed to further study the complex pathogene...

(This article belongs to the Special Issue 3D Cell Culture Cancer Models: Development and Applications)
  • Article
  • Open Access
66 Citations
9,201 Views
18 Pages

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma

  • Nethanel Asher,
  • Guy Ben-Betzalel,
  • Shaked Lev-Ari,
  • Ronnie Shapira-Frommer,
  • Yael Steinberg-Silman,
  • Neta Gochman,
  • Jacob Schachter,
  • Tomer Meirson and
  • Gal Markel

18 August 2020

Background: Immunotherapy has drastically changed the outlook for melanoma patients over the past decade. Specifically, the dual blockade of immune checkpoints using ipilimumab and nivolumab has shown unprecedented response rates and survival outcome...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
115 Citations
8,464 Views
14 Pages

Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells

  • JebaMercy Gnanasekaran,
  • Adi Binder Gallimidi,
  • Elias Saba,
  • Karthikeyan Pandi,
  • Luba Eli Berchoer,
  • Esther Hermano,
  • Sarah Angabo,
  • Hasna′a Makkawi,
  • Arin Khashan and
  • Gabriel Nussbaum
  • + 2 authors

18 August 2020

Porphyromonas gingivalis is a member of the dysbiotic oral microbiome associated with oral inflammation and periodontal disease. Intriguingly, epidemiological studies link P. gingivalis to an increased risk of pancreatic cancer. Given that oral bacte...

(This article belongs to the Special Issue Recent Advances in Pancreatic Ductal Adenocarcinoma)
  • Article
  • Open Access
18 Citations
3,782 Views
15 Pages

Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma

  • Fei Xu,
  • Lulu Zhang,
  • Yuxia Xu,
  • Di Song,
  • Wenting He,
  • Xiaomeng Ji and
  • Jianyong Shao

18 August 2020

Presently, there is a lack of effective blood-based biomarkers facilitating the diagnosis of hepatocellular carcinoma (HCC). Thus, we aimed to investigate novel methylation markers for HCC diagnosis, and explore relationships between biomarker methyl...

  • Feature Paper
  • Article
  • Open Access
25 Citations
5,614 Views
11 Pages

18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features

  • Xiang Zhou,
  • Alexander Dierks,
  • Olivia Kertels,
  • Malte Kircher,
  • Andreas Schirbel,
  • Samuel Samnick,
  • Andreas K. Buck,
  • Sebastian Knorz,
  • David Böckle and
  • Constantin Lapa
  • + 6 authors

18 August 2020

This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/compu...

(This article belongs to the Special Issue PET/CT in Multiple Myeloma Patients)
  • Review
  • Open Access
91 Citations
15,079 Views
31 Pages

Evolution of the Experimental Models of Cholangiocarcinoma

  • Annamaria Massa,
  • Chiara Varamo,
  • Francesca Vita,
  • Simona Tavolari,
  • Caterina Peraldo-Neia,
  • Giovanni Brandi,
  • Alessandro Rizzo,
  • Giuliana Cavalloni and
  • Massimo Aglietta

17 August 2020

Cholangiocarcinoma (CCA) is a rare, aggressive disease with poor overall survival. In advanced cases, surgery is often not possible or fails; in addition, there is a lack of effective and specific therapies. Multidisciplinary approaches and advanced...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
12 Citations
3,844 Views
14 Pages

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials

  • Jan Haussmann,
  • Wilfried Budach,
  • Stefanie Corradini,
  • David Krug,
  • Balint Tamaskovics,
  • Edwin Bölke,
  • Freddy-Joel Djiepmo-Njanang,
  • Ioannis Simiantonakis,
  • Kai Kammers and
  • Christiane Matuschek

17 August 2020

Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, th...

(This article belongs to the Special Issue Neoadjuvant Systemic Therapy in Early Breast Cancer)
  • Article
  • Open Access
17 Citations
4,952 Views
20 Pages

17 August 2020

Background: Malignant pleural mesothelioma (MPM) is driven by the inactivation of tumor suppressor genes (TSGs). An unmet need in the field is the translation of the genomic landscape into effective TSG-specific therapies. Methods: We correlated geno...

(This article belongs to the Special Issue Malignant Mesothelioma)
  • Perspective
  • Open Access
81 Citations
7,022 Views
11 Pages

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma

  • Belinda A. Campbell,
  • Julia J. Scarisbrick,
  • Youn H. Kim,
  • Ryan A. Wilcox,
  • Christopher McCormack and
  • H. Miles Prince

17 August 2020

Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary cutaneous T-cell lymphomas (CTCL), with utility as a surrogate marker for the “duration of clinical benefit”. TTNT provides a highly clinically meaningfu...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
7 Citations
6,433 Views
24 Pages

Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia

  • Giorgio Aquila,
  • Andrea David Re Cecconi,
  • Mara Forti,
  • Roberta Frapolli,
  • Ezia Bello,
  • Deborah Novelli,
  • Ilaria Russo,
  • Simonetta Andrea Licandro,
  • Lidia Staszewsky and
  • Rosanna Piccirillo
  • + 11 authors

17 August 2020

Trabectedin (ET743) and lurbinectedin (PM01183) limit the production of inflammatory cytokines that are elevated during cancer cachexia. Mice carrying C26 colon adenocarcinoma display cachexia (i.e., premature death and body wasting with muscle, fat...

  • Article
  • Open Access
72 Citations
8,234 Views
17 Pages

Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe

  • Carin A. Uyl-de Groot,
  • Renaud Heine,
  • Marieke Krol and
  • Jaap Verweij

17 August 2020

Background. Many new cancer medicines have been developed that can improve patients’ outcomes. However, access to these agents comes later in Europe than in the United States (US). The aim of this study is to assess the access in Europe to newl...

(This article belongs to the Section Cancer Informatics and Big Data)
  • Review
  • Open Access
15 Citations
5,440 Views
21 Pages

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review

  • Marta Dudzińska,
  • Michał Szczyrek,
  • Kamila Wojas-Krawczyk,
  • Joanna Świrska,
  • Izabela Chmielewska and
  • Agnieszka Zwolak

17 August 2020

In recent years, we have observed significant progress in cancer treatment associated with the development of immunotherapy. A programmed cell death 1 molecule (PD-1) on the surface of T lymphocytes may be stimulated via a specific PD-ligand 1 (PD-L1...

  • Review
  • Open Access
24 Citations
12,537 Views
26 Pages

Trends in Bone Metastasis Modeling

  • Roberta Laranga,
  • Serena Duchi,
  • Toni Ibrahim,
  • Ania Naila Guerrieri,
  • Davide Maria Donati and
  • Enrico Lucarelli

17 August 2020

Bone is one of the most common sites for cancer metastasis. Bone tissue is composed by different kinds of cells that coexist in a coordinated balance. Due to the complexity of bone, it is impossible to capture the intricate interactions between cells...

(This article belongs to the Special Issue 3D Cell Culture Cancer Models: Development and Applications)
  • Review
  • Open Access
47 Citations
7,915 Views
27 Pages

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge

  • Federica Marmorino,
  • Alessandra Boccaccino,
  • Marco Maria Germani,
  • Alfredo Falcone and
  • Chiara Cremolini

17 August 2020

The introduction of checkpoint inhibitors provided remarkable achievements in several solid tumors but only 5% of metastatic colorectal cancer (mCRC) patients, i.e., those with bearing microsatellite instable (MSI-high)/deficient DNA mismatch repair...

(This article belongs to the Special Issue Metastatic Colorectal Cancer)
  • Article
  • Open Access
12 Citations
5,265 Views
16 Pages

17 August 2020

Pathogenic germline variants in Breast Cancer 1/2 (BRCA) genes confer increased cancer risk. Understanding BRCA status/risk can enable family cascade screening and improve cancer outcomes. However, more than half of the families do not communicate fa...

(This article belongs to the Section Methods and Technologies Development)
  • Article
  • Open Access
26 Citations
4,617 Views
17 Pages

The Clinicopathological Characteristics And Genetic Alterations of Signet-ring Cell Carcinoma in Gastric Cancer

  • Kuo-Hung Huang,
  • Ming-Huang Chen,
  • Wen-Liang Fang,
  • Chien-Hsing Lin,
  • Yee Chao,
  • Su-Shun Lo,
  • Anna Fen-Yau Li,
  • Chew-Wun Wu and
  • Yi-Ming Shyr

17 August 2020

Signet-ring cell carcinoma (SRC) in advanced gastric cancer (GC) is often associated with more invasiveness and a worse prognosis than other cell types. The genetic alterations associated with gastric carcinogenesis in SRC are still unclear. In this...

  • Article
  • Open Access
38 Citations
7,521 Views
21 Pages

Comparison of Hydrogels for the Development of Well-Defined 3D Cancer Models of Breast Cancer and Melanoma

  • Rafael Schmid,
  • Sonja K. Schmidt,
  • Jonas Hazur,
  • Rainer Detsch,
  • Evelyn Maurer,
  • Aldo R. Boccaccini,
  • Julia Hauptstein,
  • Jörg Teßmar,
  • Torsten Blunk and
  • Annika Kengelbach-Weigand
  • + 5 authors

17 August 2020

Bioprinting offers the opportunity to fabricate precise 3D tumor models to study tumor pathophysiology and progression. However, the choice of the bioink used is important. In this study, cell behavior was studied in three mechanically and biological...

(This article belongs to the Special Issue 3D Cell Culture Cancer Models: Development and Applications)
  • Article
  • Open Access
96 Citations
8,711 Views
21 Pages

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

  • Jakob M. Riedl,
  • Dominik A. Barth,
  • Wolfgang M. Brueckl,
  • Gloria Zeitler,
  • Vasile Foris,
  • Stefanie Mollnar,
  • Michael Stotz,
  • Christopher H. Rossmann,
  • Angelika Terbuch and
  • Florian Posch
  • + 9 authors

17 August 2020

Background: Biomarkers for predicting response to immune checkpoint inhibitors (ICI) are scarce and often lack external validation. This study provides a comprehensive investigation of pretreatment C-reactive protein (CRP) levels as well as its longi...

(This article belongs to the Section Cancer Biomarkers)
  • Brief Report
  • Open Access
15 Citations
5,539 Views
10 Pages

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland

  • Emilia Rogoża-Janiszewska,
  • Karolina Malińska,
  • Cezary Cybulski,
  • Anna Jakubowska,
  • Jacek Gronwald,
  • Tomasz Huzarski,
  • Marcin Lener,
  • Bohdan Górski,
  • Wojciech Kluźniak and
  • on behalf of the Polish Hereditary Breast Cancer Consortium
  • + 6 authors

17 August 2020

There are twenty recurrent mutations in six breast-cancer-predisposing genes in Poland (BRCA1, BRCA2, CHEK2, PALB2, NBN, and RECQL). The frequencies of the twenty alleles have not been measured in a large series of early-onset breast cancer patients...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Review
  • Open Access
92 Citations
18,279 Views
23 Pages

Retinoblastoma: Etiology, Modeling, and Treatment

  • Rossukon Kaewkhaw and
  • Duangnate Rojanaporn

16 August 2020

Retinoblastoma is a retinal cancer that is initiated in response to biallelic loss of RB1 in almost all cases, together with other genetic/epigenetic changes culminating in the development of cancer. RB1 deficiency makes the retinoblastoma cell-of-or...

(This article belongs to the Special Issue Retinoblastoma—Current Therapeutic Challenges and Promising New Approaches)
  • Article
  • Open Access
19 Citations
3,918 Views
16 Pages

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis

  • Claudia Orrù,
  • Andrea Perra,
  • Marta Anna Kowalik,
  • Sabrina Rizzolio,
  • Elisabetta Puliga,
  • Lavinia Cabras,
  • Silvia Giordano and
  • Amedeo Columbano

16 August 2020

Activation of the Nrf2-Keap1 pathway, the main intracellular defense against environmental stress, has been observed in several human cancers, including hepatocellular carcinoma (HCC). Here, we assessed whether distinct mechanisms of activation may b...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
62 Citations
5,741 Views
15 Pages

Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas

  • Camilo Jimenez,
  • Vivek Subbiah,
  • Bettzy Stephen,
  • Junsheng Ma,
  • Denai Milton,
  • Mingxuan Xu,
  • Abdualrazzak Zarifa,
  • Fechukwu Omolara Akhmedzhanov,
  • Apostolia Tsimberidou and
  • Aung Naing
  • + 3 authors

16 August 2020

Metastatic pheochromocytomas and paragangliomas (MPPGs) are rare endocrine malignancies that are associated with high rates of morbidity and mortality because of their large tumor burden and location, progression, and release of catecholamines. Syste...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
53 Citations
6,123 Views
14 Pages

The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial

  • Eun Jung Park,
  • Jeong-Heum Baek,
  • Gyu-Seog Choi,
  • Won Cheol Park,
  • Chang Sik Yu,
  • Sung-Bum Kang,
  • Byung Soh Min,
  • Jae Hwang Kim,
  • Hyeong Rok Kim and
  • Seung Hyuk Baik
  • + 5 authors

16 August 2020

We aimed to assess the survival benefits of primary tumor resection (PTR) followed by chemotherapy in patients with asymptomatic stage IV colorectal cancer with asymptomatic, synchronous, unresectable metastases compared to those of upfront chemother...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
66 Citations
5,493 Views
14 Pages

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

  • Auris Huen,
  • Bradley M. Haverkos,
  • Jasmine Zain,
  • Ramchandren Radhakrishnan,
  • Mary Jo Lechowicz,
  • Sumana Devata,
  • Neil J. Korman,
  • Lauren Pinter-Brown,
  • Yasuhiro Oki and
  • Swaminathan P. Iyer
  • + 5 authors

15 August 2020

Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a phase I/Ib study for maximum tolerated dose (MTD), pharmacokinetics, and efficacy in patients with relapsed/refractory peripheral and cutaneous T-Cell L...

  • Article
  • Open Access
26 Citations
4,719 Views
19 Pages

SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation

  • Alexandra Elisabeth Wagner,
  • Thomas Schwarzmayr,
  • Beate Häberle,
  • Christian Vokuhl,
  • Irene Schmid,
  • Markus Kaller,
  • Heiko Hermeking,
  • Dietrich von Schweinitz and
  • Roland Kappler

15 August 2020

Hepatoblastoma (HB) is the most common malignant liver tumor in childhood and it generally has a good prognosis. However, if associated with aggressive metastatic disease, outcome is still poor. The molecular mechanisms leading to metastatic spread i...

(This article belongs to the Special Issue Theranostic Advances in Hepatobiliary Tumors)
  • Article
  • Open Access
10 Citations
4,655 Views
15 Pages

Impact of Vasectomy on the Development and Progression of Prostate Cancer: Preclinical Evidence

  • Takashi Kawahara,
  • Yuki Teramoto,
  • Yi Li,
  • Hitoshi Ishiguro,
  • Jennifer Gordetsky,
  • Zhiming Yang and
  • Hiroshi Miyamoto

15 August 2020

Some observational studies have implied a link between vasectomy and an elevated risk of prostate cancer. We investigated the impact of vasectomy on prostate cancer outgrowth, mainly using preclinical models. Neoplastic changes in the prostate were c...

(This article belongs to the Collection Prostate Cancer—from Molecular Mechanisms to Clinical Care)
  • Article
  • Open Access
13 Citations
3,470 Views
16 Pages

15 August 2020

Anti-apoptotic BCL2 proteins are important targets for cancer therapy as cancers depend on their activity for survival. Direct inhibitors of MCL1 have entered clinical trials, although their efficacy may be limited by toxicity. An alternative approac...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
152 Citations
10,919 Views
32 Pages

Transcription Factors in Cancer Development and Therapy

  • Kanchan Vishnoi,
  • Navin Viswakarma,
  • Ajay Rana and
  • Basabi Rana

15 August 2020

Cancer is a multi-step process and requires constitutive expression/activation of transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical for carcinogenesis. These include pro-inflammatory TFs, hypoxia-induci...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
44 Citations
11,089 Views
18 Pages

Lymphatic Valves and Lymph Flow in Cancer-Related Lymphedema

  • Drishya Iyer,
  • Melanie Jannaway,
  • Ying Yang and
  • Joshua P. Scallan

15 August 2020

Lymphedema is a complex disease caused by the accumulation of fluid in the tissues resulting from a dysfunctional or damaged lymphatic vasculature. In developed countries, lymphedema most commonly occurs as a result of cancer treatment. Initially, im...

(This article belongs to the Special Issue Cancer Related Lymphedema)
  • Article
  • Open Access
29 Citations
4,425 Views
11 Pages

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

  • Takahiro Wakasaki,
  • Ryuji Yasumatsu,
  • Muneyuki Masuda,
  • Toranoshin Takeuchi,
  • Tomomi Manako,
  • Mioko Matsuo,
  • Rina Jiromaru,
  • Ryutaro Uchi,
  • Noritaka Komune and
  • Takashi Nakagawa
  • + 1 author

15 August 2020

Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT a...

(This article belongs to the Special Issue C-Reactive Protein in Cancer)
  • Article
  • Open Access
61 Citations
5,470 Views
20 Pages

Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition

  • Rofaida Gaballa,
  • Hamdy E. A. Ali,
  • Mohamed O. Mahmoud,
  • Johng S. Rhim,
  • Hamed I. Ali,
  • Heba F. Salem,
  • Mohammad Saleem,
  • Mohamed A. Kandeil,
  • Stefan Ambs and
  • Zakaria Y. Abd Elmageed

15 August 2020

Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
8 Citations
3,689 Views
13 Pages

Evaluation of Uterine Brachytherapy as Primary Treatment Option for Elderly Patients with Medically Inoperable Endometrial Cancer—A Single-Center Experience and Review of the Literature

  • Nathalie Arians,
  • Jan Tobias Oelmann-Avendano,
  • Daniela Schmitt,
  • Eva Meixner,
  • Antje Wark,
  • Juliane Hoerner-Rieber,
  • Rami A. El Shafie,
  • Kristin Lang,
  • Markus Wallwiener and
  • Jürgen Debus

15 August 2020

We aimed to gain more evidence regarding the feasibility, toxicity, and oncological outcome of primary brachytherapy in patients with medically inoperable endometrial cancer. Thirteen patients receiving primary brachytherapy ± external beam ra...

(This article belongs to the Special Issue Radiotherapy in Endometrial Cancer)
  • Article
  • Open Access
41 Citations
7,644 Views
20 Pages

Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue

  • Alba Costales-Carrera,
  • Asunción Fernández-Barral,
  • Pilar Bustamante-Madrid,
  • Orlando Domínguez,
  • Laura Guerra-Pastrián,
  • Ramón Cantero,
  • Luis del Peso,
  • Aurora Burgos,
  • Antonio Barbáchano and
  • Alberto Muñoz

15 August 2020

Colon and rectal tumors, often referred to as colorectal cancer, show different gene expression patterns in studies that analyze whole tissue biopsies containing a mix of tumor and non-tumor cells. To better characterize colon and rectal tumors, we i...

(This article belongs to the Special Issue Stemness and Differentiation in Cancer)
  • Article
  • Open Access
17 Citations
5,897 Views
15 Pages

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2

  • Verena Barbarino,
  • Sinika Henschke,
  • Stuart James Blakemore,
  • Elena Izquierdo,
  • Michael Michalik,
  • Nadine Nickel,
  • Indra Möllenkotte,
  • Daniela Vorholt,
  • Linda Müller and
  • Christian P. Pallasch
  • + 5 authors

15 August 2020

Targeted inhibition of Bruton’s Tyrosine Kinase (BTK) with ibrutinib and other agents has become important treatment options in chronic lymphocytic leukemia, Waldenström’s Macroglobulinemia, Mantle cell lymphoma, and non-GCB DLBCL. Clinical trials co...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
128 Citations
14,090 Views
27 Pages

Mechanisms of T-Cell Exhaustion in Pancreatic Cancer

  • Didem Saka,
  • Muazzez Gökalp,
  • Betül Piyade,
  • Nedim Can Cevik,
  • Elif Arik Sever,
  • Derya Unutmaz,
  • Güralp O. Ceyhan,
  • Ihsan Ekin Demir and
  • Hande Asimgil

14 August 2020

T-cell exhaustion is a phenomenon that represents the dysfunctional state of T cells in chronic infections and cancer and is closely associated with poor prognosis in many cancers. The endogenous T-cell immunity and genetically edited cell therapies...

(This article belongs to the Collection Mechanism of Immunotherapy in Cancers)
  • Feature Paper
  • Review
  • Open Access
14 Citations
5,099 Views
18 Pages

14 August 2020

All-trans retinoic acid (RA), which is the dietary bioactive derivative obtained from animal (retinol) and plant sources (beta-carotene), is a physiological lipid signal of both embryonic and postembryonic development. During pregnancy, either RA def...

(This article belongs to the Collection Regulatory and Non-Coding RNAs in Cancer Epigenetic Mechanisms)
  • Review
  • Open Access
228 Citations
14,956 Views
34 Pages

Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach

  • Zeinab Nouri,
  • Sajad Fakhri,
  • Keyvan Nouri,
  • Carly E. Wallace,
  • Mohammad Hosein Farzaei and
  • Anupam Bishayee

14 August 2020

Multiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The conventional therapies used in cancer prevention/treatment suffer from low efficacy, considerable toxicity, and high cost. Hence, the discovery and development...

(This article belongs to the Special Issue Medicinal Plants and Their Active Ingredients in Cancer)
  • Review
  • Open Access
16 Citations
4,820 Views
25 Pages

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

  • Andrew T. Kuykendall,
  • Nathan P. Horvat,
  • Garima Pandey,
  • Rami Komrokji and
  • Gary W. Reuther

14 August 2020

Myelofibrosis (MF) is a myeloproliferative neoplasm hallmarked by the upregulation of the Janus kinase (JAK)—signal transducer and activator of transcription (STAT) pathway with associated extramedullary hematopoiesis and a high burden of disea...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Article
  • Open Access
18 Citations
5,656 Views
17 Pages

RETRACTED: Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo

  • Alexandra Thomas,
  • Abhilash Samykutty,
  • Jorge G. Gomez-Gutierrez,
  • Wenyuan Yin,
  • Michael E. Egger,
  • Molly McNally,
  • Phillip Chuong,
  • William M. MacCuaig,
  • Sabrin Albeituni and
  • Lacey R. McNally
  • + 5 authors

14 August 2020

Pancreatic cancer remains a recalcitrant neoplasm associated with chemoresistance and high fatality. Because it is frequently resistant to apoptosis, exploiting autophagic cell death could offer a new treatment approach. We repurpose echinomycin, an...

(This article belongs to the Special Issue Recent Advances in Pancreatic Ductal Adenocarcinoma)
  • Article
  • Open Access
55 Citations
7,024 Views
14 Pages

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

  • Giuseppe Lombardi,
  • Valeria Barresi,
  • Stefano Indraccolo,
  • Michele Simbolo,
  • Matteo Fassan,
  • Susanna Mandruzzato,
  • Matteo Simonelli,
  • Mario Caccese,
  • Marco Pizzi and
  • Vittorina Zagonel
  • + 11 authors

14 August 2020

Introduction: Pembrolizumab demonstrated promising results in hypermutated tumors of diverse origin. Immunohistochemical loss of mismatch repair (MMR) proteins has been suggested as a surrogate of hypermutation in high-grade gliomas (HGG). We evaluat...

(This article belongs to the Special Issue Recurrent Glioblastoma)
  • Review
  • Open Access
33 Citations
10,174 Views
25 Pages

The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors

  • Melissa B. Aldrich,
  • John C. Rasmussen,
  • Caroline E. Fife,
  • Simona F. Shaitelman and
  • Eva M. Sevick-Muraca

14 August 2020

Breast-cancer-acquired lymphedema is routinely diagnosed from the appearance of irreversible swelling that occurs as a result of lymphatic dysfunction. Yet in head and neck cancer survivors, lymphatic dysfunction may not always result in clinically o...

(This article belongs to the Special Issue Cancer Related Lymphedema)
  • Article
  • Open Access
18 Citations
2,845 Views
15 Pages

Elderly Hepatocellular Carcinoma Patients: Open or Laparoscopic Approach?

  • Jong Man Kim,
  • Sangjin Kim,
  • Jinsoo Rhu,
  • Gyu-Seong Choi,
  • Choon Hyuck David Kwon and
  • Jae-Won Joh

14 August 2020

It remains unclear whether the short-term benefits and long-term outcomes of laparoscopic liver resection (LLR) accrue to elderly patients with medical comorbidities. The aim of the present study was to compare the outcomes between LLR and open liver...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
11 Citations
4,227 Views
22 Pages

C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation

  • Celia Sequera,
  • Paloma Bragado,
  • Sara Manzano,
  • Maria Arechederra,
  • Sylvie Richelme,
  • Alvaro Gutiérrez-Uzquiza,
  • Aránzazu Sánchez,
  • Flavio Maina,
  • Carmen Guerrero and
  • Almudena Porras

14 August 2020

The complexity of hepatocellular carcinoma (HCC) challenges the identification of disease-relevant signals. C3G, a guanine nucleotide exchange factor for Rap and other Ras proteins, plays a dual role in cancer acting as either a tumor suppressor or p...

(This article belongs to the Special Issue Primary and Secondary Liver Tumors)

of 7

XFacebookLinkedIn
Cancers - ISSN 2072-6694